Aug 17, 2023, 12:25 PM
covid v2

Pharmac is seeking feedback on a proposal to make changes to the access criteria for COVID-19 antiviral treatments. 

The current access criteria for COVID-19 antivirals exclude many groups of people who would be vulnerable to severe illness from COVID-19, including many in the rare disorder community. 

Rare Disorders NZ has been advocating for the widening of access to COVID-19 antiviral treatment for some time. We wrote to Pharmac in February requesting for a review to widen the access criteria, and we are pleased to see this finally coming to fruition.

Rare Disorders NZ has made a submission to Pharmac on the proposal to change the access criteria for COVID-19 antiviral treatments. Read the full submission here.

Back to Submissions